Moderna, Inc. Dividend History (MRNA)

About Moderna, Inc.

Moderna, Inc. is a pioneering biotechnology company, founded in 2010, that focuses on developing and commercializing messenger RNA (mRNA) therapeutics and vaccines. With its headquarters in Cambridge, Massachusetts, Moderna gained significant global attention for its role in developing one of the first COVID-19 vaccines, known as Spikevax. The company was co-founded by Derrick Rossi and is currently led by CEO Stéphane Bancel. Moderna's innovative approach centers on using mRNA to direct the body's cells to produce proteins that can prevent or treat diseases, positioning it as a leader in mRNA technology. As of 2022, the company reported a revenue of over $18 billion, reflecting its pivotal role in the pandemic response. Moderna continues to expand its research and development efforts in diverse areas, including rare diseases, oncology, and personalized medicine.